Trial intelligence / Profile preview

In Vivo Imaging of Olfactory Epithelium Using Confocal Laser Endomicroscopy

NCT07546617Phase 1Not yet recruiting

Sponsor
Dartmouth Health
Start
Nov 2026
Primary completion
Apr 2027
Countries
1
01

Overview

Phase 1, open-label trial (2 arms), sponsored by Dartmouth Health. Primary endpoint: Feasibility of in vivo CLE imaging of the olfactory cleft and nasal turbinate at Day 0. Planned start Nov 2026; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07546617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07546617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call